| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-09 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-09 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-08 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-08 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-08 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-07 |